Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. European Lung Cancer Congress 2024

New biomarkers in NSCLC beyond immunotherapy

Beyond G12C: Other RAS / RAF mutation in NSCLC

Date

23 Mar 2024

Session

New biomarkers in NSCLC beyond immunotherapy

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Sanjay Popat

Authors

S. Popat

Author affiliations

  • The Royal Marsden NHS Trust, London/GB

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

New pathways including FGFR

Presenter: Noemi Reguart Aransay

Session: New biomarkers in NSCLC beyond immunotherapy

Resources:

Slides

Webcast

Q&A and discussion

Session: New biomarkers in NSCLC beyond immunotherapy

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.